Genscript Biotech Corporation
金斯瑞生物科技有限公司
China
1 November 2019 - 31 October 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Genscript Biotech Corporation published between 1 November 2019 - 31 October 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 2 | 0.15 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 2 | 0.15 | |
Top articles by Altmetric score in current window
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Nature Biotechnology
2020-07-23
First-in-class humanized FSH blocking antibody targets bone and fat.
Proceedings of the National Academy of Sciences of the United States of America
2020-10-30
1 November 2019 - 31 October 2020
International vs. domestic collaboration by Share
- 8.96% Domestic
- 91.04% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (3 total)
- Genscript Biotech Corporation, China
- Domestic institution
Top 10 international collaborators by Share (20 total)
- Genscript Biotech Corporation, China
- Foreign institution
-
Mount Sinai Health System (MSHS), United States of America (USA)
(0.71)
-
Duke-National University of Singapore (Duke-NUS), Singapore
(0.62)
-
National University of Singapore (NUS), Singapore
(0.45)
-
Duke University, United States of America (USA)
(0.37)
-
SingHealth Duke-NUS Global Health Institute (SDGHI), Singapore
(0.19)
-
National Centre for Infectious Diseases (NCID), Singapore
(0.18)
-
Singapore Health Services Pte. Ltd. (SingHealth), Singapore
(0.16)
-
Lee Kong Chian School of Medicine, Singapore
(0.15)
-
National Healthcare Group (NHG), Singapore
(0.15)
-
Agency for Science, Technology and Research (A*STAR), Singapore
(0.15)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
